Browse stocks · Browse sectors · Healthcare · Healthcare · Pharmaceuticals & Biotechnology · Pharmaceuticals

NSE RESEARCH WORKSPACE

Glaxosmithkline Pharmaceuticals Ltd

NSE: GLAXO

OverviewFinancial StatementsQuant ScoreForensic Accounting+

Price1Y

Company Overview

Glaxosmithkline Pharmaceuticals Ltd is classified in Pharmaceuticals.

Market Cap: ₹ 40,737.07 Cr.
Price in snapshot: ₹ 2,404.7
ROE: 49.12 %
ROCE: 58.34 %
Dividend Yield: 2.36 %

Snapshot updated 22 July 2026. Figures are not live quotes.

Research coverage

Concall documents: transcript for Q1 FY27, dated 6 August 2026.
Annual-report coverage: FY2026.
Company exchange-filing catalog coverage.

Browse concall documents · Browse exchange filings